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Af9 Ser435 is phosphorylated by Sgk1 in vitro and is a major phosphoryla-























Aldosterone coordinately induces Sgk1 expression and Af9 Ser435 phos-














Af9 Ser435 is phosphorylated by Sgk1 in vitro and is a major phosphorylation site in mIMCD3 cells. (A) Af9 possesses a highly conserved 
putative phosphorylation site, Ser435, for Sgk1. Shown are aa sequences surrounding Ser435 of Af9 (in bold) from different species. (B) Sgk1 
phosphorylates Af9 in vitro. GST, WT GST-Af9 397–557, or GST-Af9 397–557 Ser435Ala purified from E. coli was phosphorylated in vitro in 
the presence of [γ-32P]ATP, separated by SDS-PAGE, stained (bottom), and autoradiographed (top). Mean 32P values (in cpm) of the corre-
sponding bands are shown, with SE less than 25% in all cases (n = 3). (C) Af9 phosphorylation by Sgk1 requires Ser435. As in B, except for 
omission of [γ-32P]ATP (n = 3). (D) Af9 is phosphorylated in mIMCD3 cells. mIMCD3 cells transfected with pCMV500 vector (Vec) or pFLAG-Af9 
(F-Af9) were labeled with [32P]orthophosphate and analyzed by IP-IB with the FLAG M2 antibody. A representative autoradiograph (left) and 
corresponding IB (right) are shown (n = 3). Arrow denotes unknown protein; arrowhead denotes possibly degraded Af9 fusions. (E) Af9 Ser435 
is a major phosphorylation site in mIMCD3 cells. As in D, except that pFLAG-Af9 Ser435Ala construct (F-Af9 Ser435Ala) replaced pCMV500. 
A weak band migrating at the position of FLAG-Af9 Ser435Ala was visible after exposure of 12 more hours. Plot of the 32P signal normalized to 
the corresponding protein abundance of each Af9 fusion, with WT Af9 labeling assigned as 1 (n = 5). *P < 0.05.
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Sgk1-mediated Af9 phosphorylation decreases the Dot1a-Af9 interac-

































Af9 phosphorylation directly correlates with Sgk1 
expression in mIMCD3 cells. (A) Aldosterone coordi-
nately induces Sgk1 expression and Af9 Ser435 phos-
phorylation. mIMCD3 cells were treated with ethanol 
or aldosterone (Aldo; 1 μM) for the indicated times 
and examined by IB with the indicated antibodies. 
Af9 phosphorylation was apparently affected by both 
ethanol and aldosterone. The Sgk1 or phosphorylated 
Af9 abundance (mean ± SE; n = 6) was normalized 
to the corresponding actin and expressed relative to 
vehicle-treated cells at the 1-hour time point (assigned 
as 1). *P < 0.05 versus corresponding –aldo. (B) RNAi 
knockdown of Sgk1 decreases Af9 phosphorylation. 
mIMCD3 cells stably transfected with pSilencer-
4.1–CMV–Neo negative control vector (Vec), pSgk1-
RNAi7 (RNAi7), or pSgk1-RNAi9 (RNAi9) were exam-
ined by IB with the indicated antibodies. The same 
set of stably transfected cells were repeatedly exam-
ined as in A. Data were analyzed essentially as in A 
(n = 4). (C) Overexpression of WT Sgk1, but not the 
kinase-dead mutant Sgk1, promotes Af9 phosphory-
lation. mIMCD3 cells were transiently transfected with 
pcDNA3.1 vector (Vec) or its derivatives encoding WT 
or kinase-dead mutant Sgk1 (Lys127Met; Mut) and 
analyzed by IB probed with the indicated antibodies. 
Data were analyzed similarly as in A (n = 4). *P < 0.05 
versus vector control.
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Sgk1 impairs Af9 interaction with Dot1a in vitro. (A) GST pulldown assay showing impaired ability of Sgk1-phosphorylated Af9 to retain the 
EGFP-Dot1a fusion. As in Figure 1C, GST-Af9 397–557 was phosphorylated by Sgk1 and incubated with mIMCD3 cell lysates containing EGFP-
Dot1a 479–659. Bound proteins were examined by IB with the indicated antibodies (n = 3). (B) As in A, except for inclusion of GST-Af9 Ser435Ala 
as control, increasing input volumes (μl) of EGFP-Dot1a 479–659 lysate and the indicated antibodies. The same mIMCD3 cell lysates (3 μl) were 
loaded in the far right lane. The amount of bound EGFP-Dot1a 479–659 was normalized to that of total GST-Af9 fusions to calculate the relative 
binding efficiency and were plotted, with the efficiency of the reaction GST-Af9 397–557, –Sgk1, at 100 μl of input lysate assigned as 1 (n = 3). 
*P < 0.05 versus corresponding GST-Af9 397–557, –Sgk1.
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Sgk1 associates with and downregulates Dot1a-Af9 interaction at the ENaCα promoter. (A) Diagram of the ENaCα promoter (8). (B) ChIP 
assay showing association of WT and kinase-dead mutant Sgk1 with the R0–R3, but not Ra, subregions of the ENaCα promoter. Chromatin 
was immunoprecipitated by anti-FLAG antibody from mIMCD3 cells transfected with pCMV500, WT pFLAG-Sgk1, or mutant pFLAG-Sgk1 
Lys127Met, followed by quantitative real-time PCR with primers amplifying the Ra and R0–R3 subregions of ENaCα promoter as shown in 
A (n = 3). FLAG-Sgk1 abundance in R0 from the FLAG-Sgk1–transfected cells was assigned as 1. (C–F) ChIP and sequential ChIP assays 
demonstrating that overexpression of Sgk1 differentially affected the abundance of FLAG-Af9 (C), Dot1a (D), histone H3 Lys79 methylation 
(E), and FLAG-Af9 interaction with Dot1a (F) at the ENaCα promoter. mIMCD3 cells were cotransfected with pFLAG-Af9 and pcDNA3.1 or its 
derivatives expressing Sgk1 or its kinase-dead mutant, followed by ChIP with the indicated antibodies. For sequential ChIP (re-ChIP), chromatin 
was sequentially immunoprecipitated with anti-FLAG and anti-Dot1a antibodies. Relative ChIP or sequential ChIP efficiency was defined as the 
amount of (re)immunoprecipitated material compared with that of the initial input sample and was assigned as 1 in R0 from vector-transfected 
cells (n = 3–6). No Ra expression was detected in B, C, or F. *P < 0.05 versus vector control.
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Mutation of the Sgk1 phosphorylation site Ser435 in Af9 impairs Af9 
overexpression–dependent histone H3 Lys79 hypermethylation, but not 






































Af9 Ser435Ala and Ser435Asp mutations impair 
Af9 overexpression–dependent histone H3 Lys79 
hypermethylation and ENaCα promoter repres-
sion. (A) ChIP assay showing that Af9 Ser435Ala 
and Ser435Asp mutations decreased Dot1a-
Af9–mediated histone H3 Lys79 methylation, but 
not Af9 association with the ENaCα promoter, 
in mIMCD3 cells. pFLAG-Af9, pFLAG-Af9 Ser-
435Ala, and pFLAG-Af9 Ser435Asp were used, 
and ChIP assays were performed with the indi-
cated antibodies (n = 3–4). The relative histone 
H3 Lys79 methylation of R0 from the vector-
transfected cells was assigned as 1. Representa-
tive agarose gel analyses of the final quantitative 
PCR products are shown to verify the quantifica-
tion determined by quantitative real-time PCR for 
each sample. (B) Luciferase assay indicating that 
the Ser435Ala mutation impaired Af9-dependent 
repression of ENaCα promoter activity. mIMCD3 
cells stably carrying pGL3Zeocin-1.3ENaCα 
(12) were transiently transfected with pCMV500, 
pFLAG-Af9, or pFLAG-Af9 Ser435Ala, followed 
by luciferase assay (n = 4). *P < 0.05 versus vec-
tor control. (C) Quantitative RT-PCR (qRT-PCR) 
demonstrating that the Ser435Ala mutation 
partially relieves Af9-dependent repression of 
endogenous ENaCα transcription. As in B, except 
that total RNA was analyzed by quantitative real-
time RT-PCR with primers specific for ENaCα or 
β-actin as control and that whole-cell lysates 
were examined by IP with the indicated anti-
bodies. The relative level of ENaCα mRNA was 
normalized to actin in the same sample, and that 
of vector-transfected cells was assigned as 1. 
The means of 3 independent measurements with 
SE less than 20% are shown.
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probably induces conformational changes in Af9 that weakens Af9 
binding to Dot1a (see Discussion).
Mutation of the Sgk1 phosphorylation site Ser435 in Af9 partially relieves 



















Af9 phosphorylation and Sgk1 mRNA expression are coordinately regu-






























Sgk1 phosphorylates Af9 and regulates transcription of ENaCα and other aldosterone target genes in vivo in mouse kidneys. (A and B) Low-salt 
diet coordinately increases Af9 phosphorylation and mRNA expression of Sgk1 and ENaCα in mouse kidneys. Whole lysates from the right kid-
neys of WT mice (Sgk1+/+) fed the indicated diet were pooled within the group (n = 3 in each group, similar for B–E) and analyzed by IB probed 
with the antibodies shown. Similarly, total RNA from the left kidneys was pooled within the group (n = 3) and analyzed with primers specific for the 
indicated genes. Representative agarose gel analyses of the final quantitative RT-PCR with the mean of 3 different measurements are shown. 
SEM was less than 20% in all cases. (C–E) Af9 phosphorylation is regulated by salt intake, is achieved in an Sgk1-dependent or -independent 
manner, and correlates with expression of several aldosterone target genes. As in A, except that Sgk1+/+ mice or their age- and sex-matched 
Sgk1–/– littermates fed the indicated diets were used and that additional aldosterone target genes were examined (n = 3 for each group and 
condition). Arrow denotes unknown protein. CTGF, connecting tissue growth factor.
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Model for aldosterone-sensitive repression of ENaCα expression by 
targeted histone H3 Lys79 hypermethylation mediated by the Dot1a-
Af9-Sgk1 complex. Under basal conditions, Dot1a and Af9 form a 
nuclear complex that directly or indirectly binds specific sites of the 
ENaCα promoter, leading to hypermethylation of histone H3 Lys79 
and repression of ENaCα transcription. Aldosterone stimulates ENaCα 
transcription by regulating 2 different pathways. In the classical path-
way, aldosterone binds and activates the nuclear hormone receptors 
(NR) that are either glucocorticoid receptor and/or mineralocorticoid 
receptor homo- or heterodimers to bind the glucocorticoid response 
element in the ENaCα promoter and transactivate ENaCα. In a parallel 
pathway, aldosterone releases the repression of ENaCα by (a) down-
regulating Dot1a (12) and Af9 expression (8), and thus the amount 
of Dot1a-Af9 complex, presumably via nuclear receptor–dependent 
or –independent (not shown) mechanisms and/or (b) decreasing the 
Dot1a-Af9 interaction via Sgk1-mediated phosphorylation of Af9 to 
limit their availability, leading to histone H3 Lys79 hypomethylation at 
specific subregions of the ENaCα promoter. Sgk1 might join and down-
regulate the Dot1a-Af9 complex associated with the ENaCα promoter 
(not shown for simplicity). In all cases, Af9-free Dot1a binds DNA non-
specifically and catalyzes histone H3 Lys79 methylation throughout the 
genome under basal conditions (not shown). A hypothetical opposing 
interaction between the nuclear receptor–aldosterone complex and the 
Dot1a-Af9 complex (dotted line) may tune the ultimate level of ENaCα 
transcription. Meth, methylation.
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Cell culture, aldosterone treatment, transient and stable transfections, RNAi 




























ChIP, sequential ChIP, quantitative real-time PCR, and quantitative RT-PCR. 
ChIP-coupled quantitative real-time PCR of DNA isolated in ChIP assays 
or quantitative RT-PCR for mRNA expression were performed with SYBR 













































kidney:  site of  action,  regulation by ubiquitin 
ligases,  serum-  and  glucocorticoid-inducible 
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